scPharmaceuticals Inc.
NASDAQ:SCPH
5.26 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 46.814 | 71.061 | 74.268 | 105.277 | 72.806 | 89.66 | 118.298 | 39.282 | 1.573 |
| Short Term Investments
| 29.199 | 47.125 | 1.01 | 33.276 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 76.013 | 118.368 | 75.46 | 105.277 | 72.806 | 89.66 | 118.298 | 39.282 | 1.573 |
| Net Receivables
| 4.489 | 2.282 | 0 | 0 | 0.31 | 0.479 | 0.655 | 0.349 | 0.104 |
| Inventory
| 8.84 | 1.23 | 0 | 0 | 2.437 | 1.575 | 0.823 | 0.101 | 0.126 |
| Other Current Assets
| 3.596 | 1.428 | 0.024 | 0.121 | 0.094 | 0.179 | 0.107 | 0.008 | 0.015 |
| Total Current Assets
| 92.938 | 123.308 | 78.275 | 107.826 | 75.647 | 91.893 | 119.883 | 39.74 | 1.818 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 1.459 | 0.62 | 0.479 | 0.908 | 1.306 | 1.67 | 1.976 | 0.026 | 0.023 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0.182 | 0.182 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.082 | 0.267 | 0.283 | 0.132 | 0.148 | 0.192 | 0.189 | 0.006 | 0.005 |
| Total Non-Current Assets
| 1.541 | 0.887 | 0.762 | 1.222 | 1.636 | 1.862 | 2.165 | 0.032 | 0.028 |
| Total Assets
| 94.479 | 124.195 | 79.037 | 109.048 | 77.283 | 93.755 | 122.048 | 39.772 | 1.846 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 4.001 | 1.518 | 0.544 | 1.666 | 1.142 | 0.587 | 1.591 | 1.546 | 0.684 |
| Short Term Debt
| 0.176 | 0.567 | 10.281 | 2.868 | 0.407 | 3.164 | 0.556 | 0 | 0 |
| Tax Payables
| 0 | 0.049 | 0.005 | 0.04 | 0.049 | 0.165 | 0.192 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 3.995 | 0 | 0 | 2.569 | 3.063 | 0 | 0 |
| Other Current Liabilities
| 8.957 | 5.331 | 0.026 | 4.787 | 3.688 | 0.353 | 0.001 | 2.19 | 1.321 |
| Total Current Liabilities
| 13.134 | 7.416 | 14.846 | 9.321 | 5.237 | 6.673 | 5.211 | 3.736 | 2.005 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 38.811 | 36.801 | 7.354 | 17.338 | 19.858 | 8.179 | 10.788 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 5.316 | 7.545 | 0.367 | 0.219 | 0.823 | 0.159 | 0.052 | 73.11 | 18.081 |
| Total Non-Current Liabilities
| 44.127 | 44.346 | 7.721 | 17.557 | 20.681 | 8.338 | 10.84 | 73.11 | 18.081 |
| Total Liabilities
| 57.261 | 51.762 | 22.567 | 26.878 | 25.918 | 15.011 | 16.051 | 76.846 | 20.086 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 120.275 | 73.103 | 18.073 |
| Common Stock
| 0.004 | 0.003 | 0.003 | 0.003 | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 |
| Retained Earnings
| -281.346 | -226.536 | -189.698 | -161.664 | -129.455 | -96.459 | -67.016 | -43.199 | -18.822 |
| Accumulated Other Comprehensive Income/Loss
| -0.001 | 0.032 | -0.001 | 0.001 | 0 | -0.6 | -0.026 | -0.009 | -0.004 |
| Other Total Stockholders Equity
| 318.561 | -0.035 | -0.002 | -0.004 | -0.002 | 0.598 | 52.762 | -66.97 | -17.488 |
| Total Shareholders Equity
| 37.218 | -226.536 | -189.698 | -161.664 | -129.455 | -96.459 | 105.997 | -37.074 | -18.24 |
| Total Equity
| 37.218 | -226.536 | -189.698 | -161.664 | -129.455 | -96.459 | 105.997 | -37.074 | -18.24 |
| Total Liabilities & Shareholders Equity
| 94.479 | -174.774 | -167.131 | -134.786 | -103.537 | -81.448 | 122.048 | 39.772 | 1.846 |